Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Champion Homes | SKY | 3. fév 2025 | 91.70 | -0.68 |
Champions Oncology | CSBR | 3. fév 2025 | 10.01 | -8.92 |
ChampionX | CHX | 3. fév 2025 | 28.53 | -0.38 |
Channel Therapeutics | CHRO | 3. fév 2025 | 2.13 | -8.97 |
Chanson International | CHSN | 3. fév 2025 | 0.46 | -13.85 |
ChargePoint | CHPT | 3. fév 2025 | 0.93 | -3.35 |
Charles & Colvard | CTHR | 3. fév 2025 | 1.43 | -0.67 |
Charles River Laboratories International | CRL | 3. fév 2025 | 161.62 | -1.91 |
Charles Schwab | SCHW | 3. fév 2025 | 82.75 | +0.04 |
Charlton Aria Acquisition | CHAR | 3. fév 2025 | 10.02 | 0.00 |
Charlton Aria Acquisition Unit | CHARU | 3. fév 2025 | 10.20 | 0.00 |
Chart Industries | GTLS-B | 3. fév 2025 | 77.02 | -0.94 |
Chart Industries | GTLS | 3. fév 2025 | 208.89 | -1.28 |
Charter Communications A | CHTR | 3. fév 2025 | 341.50 | -1.15 |
Chatham Lodging Trust (REIT) A Pref | CLDT-A | 3. fév 2025 | 21.14 | +1.12 |
Chatham Lodging Trust REIT | CLDT | 3. fév 2025 | 8.68 | -0.69 |
Cheche Group | CCG | 3. fév 2025 | 0.86 | -2.16 |
Check Point Software Technolgies | CHKP | 3. fév 2025 | 213.87 | -1.90 |
Check-Cap | CHEK | 3. fév 2025 | 0.84 | -6.00 |
Checkpoint Therapeutics | CKPT | 3. fév 2025 | 3.17 | +11.62 |
Cheer Holding | CHR | 3. fév 2025 | 2.49 | -3.86 |
Cheetah Mobile ADR | CMCM | 3. fév 2025 | 4.45 | -0.22 |
Cheetah Net Supply Chain Service | CTNT | 3. fév 2025 | 2.12 | -1.85 |
Chegg | CHGG | 3. fév 2025 | 1.44 | -6.49 |
Chemed | CHE | 3. fév 2025 | 555.20 | -1.21 |
Chemomab Therapeutics ADR | CMMB | 3. fév 2025 | 2.13 | +4.41 |
Chemours | CC | 3. fév 2025 | 18.04 | -5.00 |
Chemung Financial | CHMG | 3. fév 2025 | 50.28 | -0.53 |
Chenghe Acquisition I Co A | LATG | 3. fév 2025 | 11.90 | 0.00 |
Chenghe Acquisition I Units | LATGU | 3. fév 2025 | 11.45 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.